GlassScriptPhysician profile
Matthew I Lyons
NPI 1457714933
$5,113.28
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,359 · 2024: $3,604 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,857 · Travel and Lodging: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,857.00 |
| Travel and Lodging | $756.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,085.77 | 2023-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,035.96 | 2023 | Monarch |
| Ethicon INC. | $207.05 | 2023-2024 | Monarch Platform |
| Siemens Medical Solutions USA, INC. | $143.18 | 2024 | Cios Spin |
| Inspire Medical Systems, INC. | $142.85 | 2024 | Inspire |
| Galvanize Therapeutics, INC | $134.50 | 2024 | Aliya System |
| Pinnacle Biologics, INC | $80.00 | 2025 | Photofrin |
| Merck Sharp & Dohme LLC | $51.66 | 2023-2024 | Zerbaxa, Recarbrio, Winrevair |
| Astrazeneca Pharmaceuticals LP | $44.16 | 2023-2024 | Tezspire, Breztri |
| Inari Medical, INC. | $39.69 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $31.42 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.11 | 2024 | Ofev |
| Glaxosmithkline, LLC. | $26.92 | 2023 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $21.93 | 2024 | Xarelto |
| Sumitomo Pharma America, INC. | $20.87 | 2025 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.